News & Perspective

Mar 20, 2019

Mar 20, 2019

Stewardship / Resistance Scan for Mar 20, 2019

Gloves, gowns, and MDROs
WHO drug-resistant TB guidelines
Antibiotic development partnership
Lung disease bacteria in tap water

Mar 19, 2019

Mar 19, 2019
Using stethoscope to assess lungs

Report highlights success, challenges in fight to end TB

Though incidence is down, treatment success for resistant strains is low.

Mar 14, 2019

Mar 14, 2019
Mycobacterium tuberculosis bacteria

Trial data support shorter drug-resistant TB regimen

Short-course therapy led to a favorable outcome in 79% of patients, compared with 80% in long-course patients.

Mar 11, 2019

Mar 11, 2019

Stewardship / Resistance Scan for Mar 11, 2019

VA outpatient prescribing
FDA to review new TB drug

Feb 08, 2019

Feb 08, 2019

Stewardship / Resistance Scan for Feb 08, 2019

Inadequate TB drug-susceptibility testing
New UK guidance on antibiotics for acute cough

Jan 09, 2019

Jan 09, 2019
Doctor prescribing using electronic tablet

Study sheds more light on delamanid role in treating MDR-TB

Safety profile was good, and sensitivity analysis favored delamanid as part of MDR-TB treatment.

Nov 02, 2018

Nov 02, 2018

News Scan for Nov 02, 2018

Polio in 4 countries
Avian flu in Minnesota, Vietnam
Testing for very resistant TB
New CWD type in moose?

Oct 19, 2018

Oct 19, 2018

Stewardship / Resistance Scan for Oct 19, 2018

Undetected MDR-TB in South Africa
Carbapenem prescribing algorithm

Sep 27, 2018

Sep 27, 2018
DNA test genetic sequencing

Study heralds genetic era of TB drug susceptibility testing

Whole-genome sequencing could lead to faster, more accurate resistance testing.

Sep 18, 2018

Sep 18, 2018
Mycobacterium tuberculosis bacteria

WHO report warns efforts to end TB are falling short

TB remains high in many low- and middle-income nations, and about 558,000 people in 2017 developed rifampicin-resistant TB.

Pages

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»